SYMPTOM IMPROVEMENT ASSOCIATED WITH LURASIDONE TREATMENT OF CHILDREN AND ADOLESCENTS WITH BIPOLAR I DEPRESSION: RESULTS OF A SHORT-TERM PLACEBO-CONTROLLED TRIAL

被引：1
|
作者：
Singh, Manpreet K. [1 ]
Goldman, Robert [2 ]
Tocco, Michael [2 ]
Pikalov, Andrei A. [2 ]
Deng, Ling [2 ]
Cucchiaro, Josephine [2 ]
Loebel, Antony [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2017年 / 56卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2017.09.333
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
5.50
引用
收藏
页码：S271 / S272
页数：3
相关论文
共 50 条
  • [1] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: Results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S79 - S80
  • [2] Symptom improvement associated with lurasidone treatment of children and adolescents with bipolar I depression: results of a short-term placebo-controlled trial
    Singh, M.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 66
  • [3] C-reactive protein and response to lurasidone treatment in children and, adolescents with bipolar I depression: Results from a placebo-controlled trial
    Raison, Charles L.
    Siu, Cynthia
    Pikalov, Andrei
    Tocco, Michael
    Loebel, Antony
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 84 : 269 - 274
  • [4] EFFECT OF LURASIDONE ON NEUROCOGNITIVE PERFORMANCE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A PLACEBO-CONTROLLED SHORT-TERM STUDY AND AN OPEN-LABEL EXTENSION STUDY
    Burdick, Katherine E.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S266 - S266
  • [5] Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
    DelBello, Melissa P.
    Goldman, Robert
    Phillips, Debra
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (12): : 1015 - 1025
  • [6] LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION ASSOCIATED WITH MIXED (SUBSYNDROMAL HYPOMANIC) FEATURES: POST HOC ANALYSIS OF A RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Pikalov, Andrei A.
    Siu, Cynthia
    Tocco, Michael
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S169 - S169
  • [7] Lurasidone for the treatment of schizophrenia: pooled analysis of short-term, placebo-controlled trials
    Murthy, V.
    Cucchiaro, J.
    Pikalov, A.
    Xu, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S485 - S486
  • [8] Lurasidone in children and adolescents with bipolar depression associated with mixed (Subsyndromal Hypomanic) features: post-hoc analysis of a randomized placebo-controlled trial
    Tocco, M.
    Pikalov, A.
    Siu, C.
    Loebel, A.
    BIPOLAR DISORDERS, 2018, 20 : 66 - 67
  • [9] The value of early improvement as a predictor of short-term response during treatment of bipolar depression with lurasidone
    Iosifescu, D. V.
    Tsai, J.
    Pikalov, A.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    BIPOLAR DISORDERS, 2015, 17 : 88 - 88
  • [10] The value of early improvement as a predictor of short-term response during treatment of bipolar depression with lurasidone
    Iosifescu, D. V.
    Tsai, J.
    Pikalov, A.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S421 - S421
12345